Regulation News

Financial regulation news from the SEC, FINRA, and government agencies. Track policy changes, enforcement actions, and compliance updates affecting markets.

WBD Shares Trade at 9% Discount to Paramount's $31 Takeover Bid Amid Regulatory Probe
Regulation James Calloway

WBD Shares Trade at 9% Discount to Paramount's $31 Takeover Bid Amid Regulatory Probe

Warner Bros. Discovery shares finished Friday at $28.17, representing a 9% discount to Paramount's $31-per-share acquisition offer. California's attorney general has opened an investigation into the proposed merger.

WBD
Alphabet Gains Amid Regulatory Scrutiny and Korean Map Approval
Regulation James Calloway

Alphabet Gains Amid Regulatory Scrutiny and Korean Map Approval

Alphabet's Class C shares advanced 1.39% to $311.43, outperforming the broader market. The company faces a new antitrust probe in Belgium while receiving a key mapping approval in South Korea.

GOOG GOOGL META MSFT SPY XLK
Indonesia's IDX Enforces Free-Float Rule, Inflation Data Looms
Regulation James Calloway

Indonesia's IDX Enforces Free-Float Rule, Inflation Data Looms

The Indonesia Stock Exchange (IDX) starts phasing in a new 15% minimum free-float requirement next week, which may compel over 200 listed companies to increase their public share offerings. Market focus also shifts to upcoming trade and inflation figures.

Walmart Settles FTC Driver Pay Case for $100M as Shares Defy Market Dip
Regulation James Calloway

Walmart Settles FTC Driver Pay Case for $100M as Shares Defy Market Dip

Walmart will pay $100 million to resolve FTC allegations it misled delivery drivers about earnings. Its stock rose 2.84% to $127.95 on Friday, outperforming the market.

WMT TGT BBY XLP
Fermi Secures Key Texas Permit for 6-GW Project Matador
Regulation James Calloway

Fermi Secures Key Texas Permit for 6-GW Project Matador

Fermi Inc. has obtained the final air-quality permit from Texas regulators for its 6-gigawatt Project Matador, allowing major construction to proceed. The stock edged lower premarket as investors also monitor a March 6 securities lawsuit deadline and a March 30 earnings call.

FRMI SIEGY
Hims & Hers Faces SEC Probe, Novo Nordisk Lawsuit as Analysts Cut Targets
Regulation James Calloway

Hims & Hers Faces SEC Probe, Novo Nordisk Lawsuit as Analysts Cut Targets

Hims & Hers Health shares held steady premarket following disclosures of an SEC probe and a patent lawsuit from Novo Nordisk. Analysts at BTIG and Citi downgraded the stock, citing regulatory risks.

HIMS NVO
AppLovin Faces Ongoing SEC Probe While Eyeing Social Platform Expansion
Regulation James Calloway

AppLovin Faces Ongoing SEC Probe While Eyeing Social Platform Expansion

AppLovin shares gained 1.6% on Friday despite confirmation of an ongoing SEC investigation. Investors are weighing regulatory risks against the company's potential expansion into social networking.

APP
Ford Shares Rise as Trade Policy Shifts, USMCA Probe Begins
Regulation James Calloway

Ford Shares Rise as Trade Policy Shifts, USMCA Probe Begins

Ford Motor Co. shares closed Friday at $14.01, up 1.7%, as markets digested a Supreme Court decision overturning emergency tariffs and the launch of a USMCA rules probe.

F SPY DIA XLI
Indonesia's Free-Float Overhaul Puts Barito Renewables in Spotlight
Regulation James Calloway

Indonesia's Free-Float Overhaul Puts Barito Renewables in Spotlight

Barito Renewables Energy closed lower as markets assess Indonesia's proposed 15% minimum free-float rule, which could force BREN to release over $1.8 billion in shares. The broader Jakarta Composite Index edged down slightly.

BYD Faces U.S. Tariff Uncertainty as Chinese Markets Reopen
Regulation James Calloway

BYD Faces U.S. Tariff Uncertainty as Chinese Markets Reopen

BYD's Shenzhen-listed shares remain at 90.27 yuan as markets reopen after holiday, with investors weighing U.S. tariff developments after Supreme Court struck down Trump-era emergency duties.

BYD
Visa Advances in Argentina Amid Mexico Regulatory Setback
Regulation James Calloway

Visa Advances in Argentina Amid Mexico Regulatory Setback

Visa shares gained 0.8% after announcing an acquisition in Argentina, though expansion plans in Mexico faced a regulatory hurdle.

V MA AXP FXI
GSK Gains on EU Asthma Drug Approval and £450M Share Repurchase
Regulation James Calloway

GSK Gains on EU Asthma Drug Approval and £450M Share Repurchase

GSK shares advanced after the European Commission approved its asthma drug Exdensur and the company launched a £450 million share repurchase. New data also highlighted the effectiveness of its RSV vaccine.

GSK